Comments
Commented by André Will-Laudien on June 30th, 2023 | 07:30 CEST
Doublers are possible! Bayer, Defence Therapeutics, BioNTech, Valneva - It is hard to believe!
In 2022, a total of 19.5 million people received the shocking diagnosis of "cancer". Current trends, unfortunately, suggest that this number will continue to rise in the coming years. However, thanks to growing research successes, there is hope that biotechnology will significantly increase the chances of survival for those affected. It is a matter of developing suitable active substances and launching modern therapies. mRNA technology has recently made a name for itself in cancer prevention. Innovative biotech companies are back on the radar of risk-conscious investors. We are on the lookout for doubling potential.
Read
Commented by André Will-Laudien on June 29th, 2023 | 08:50 CEST
100% with Clean Energy! BYD, Regenx Technologies, BASF, Siemens Energy - Recycling is becoming a challenge!
As Western governments finally take climate protection seriously, the media has focused on the areas of energy, mobility, and health. It is clear to all participants that the changes in the world's climate will lead to undesirable developments. Glaciers are melting, the Earth's temperature is rising, and our oceans are already too warm for many species. Huge investments are being made in renewable power generation and modern mobility solutions. The high growth requires access to metals. Recycling also plays a major role because it conserves valuable resources and brings raw materials back into the cycle. Some companies are making a name for themselves, and shareholders can benefit from this.
Read
Commented by Fabian Lorenz on June 29th, 2023 | 08:10 CEST
Change of favorites in hydrogen shares! ThyssenKrupp instead of Nel ASA? Can Grid Metals take off?
Is there a shift in favorites among hydrogen stocks? It certainly seems that way. While former favorites Nel ASA and Plug Power are struggling, ThyssenKrupp is making a strong entry with the IPO of Nucera. The subscription period for the hydrogen subsidiary has been running since Friday, and demand already exceeds supply. In contrast, Nel ASA and Plug Power are being left behind. The Danes, in particular, are facing technical chart challenges and are struggling to maintain the EUR 1 mark. But perhaps the hype around Nucera is an entry opportunity for the established hydrogen specialists. And what about lithium? Stocks such as Standard Lithium and Alkem have been trending nicely in recent weeks. Grid Metals has yet to gain momentum, despite plans to process lithium as early as 2024.
Read
Commented by Nico Popp on June 29th, 2023 | 07:50 CEST
Hydrogen abc - Everything about opportunities and risks: ThyssenKrupp, Daimler Truck, First Hydrogen
Hydrogen is experiencing a boom. The upcoming IPO of ThyssenKrupp subsidiary Nucera has a signal effect. At the beginning of the subscription period, the demand for the shares of the hydrogen specialist exceeded the supply. The shares are to be traded for the first time on July 5. Here we will discuss what Nucera's IPO means for the industry and where risks and opportunities lurk.
Read
Commented by Stefan Feulner on June 29th, 2023 | 07:30 CEST
The profiteers of the new super cycles - SAP, Defense Metals, Hut 8 Mining
Every new innovation takes time and is also not protected from delays. This can be clearly seen in the example of listed renewable energy companies. At the beginning of the new decade, these companies were praised with great anticipation, but disillusionment quickly set in due to the lack of sales and profits. On the other hand, the fact that this sector will prevail in the long term due to the energy turnaround is a foregone conclusion. The situation is similar for artificial intelligence and blockchain technology.
Read
Commented by Juliane Zielonka on June 28th, 2023 | 08:30 CEST
Manuka Resources, BYD, Rheinmetall - Hot commodity rally on the stock market
Manuka Resources expands mining projects in New South Wales following the acquisition of Trans-Tasman Resources. The strategic plan calls for increased gold production at Mt. Boppy Gold Mine. Carmakers struggle for profitability in China, while BYD posts a net profit of USD 2.5 billion. President Xi Jinping is promoting battery-powered vehicles with incentives for consumers. Warren Buffett reduces his BYD shareholding. Rheinmetall wins the order to supply 14 Leopard 2A4 main battle tanks to Ukraine. The order is financed by the Dutch and Danish governments. Delivery of the first vehicle is scheduled for January 2024. Rheinmetall has already delivered Marder infantry fighting vehicles and received another order.
Read
Commented by Fabian Lorenz on June 28th, 2023 | 08:05 CEST
Hydrogen vs battery shares: From Plug Power to Standard Lithium and Power Nickel?
Who does the future belong to? Hydrogen or battery technology? The truth likely lies somewhere in the middle, and both technologies will find their place. However, it is clear that batteries currently have the upper hand in the context of electromobility. This can also be seen in the stock market. While companies like Nel ASA and Plug Power are struggling, Tesla, BYD & Co. are celebrating record sales. But success is heavily dependent on the supply of raw materials. Lithium and nickel are scarce and in high demand. Standard Lithium and Power Nickel are among the profiteers. Standard Lithium is recommended as a buy by analysts with around 100% price potential. Power Nickel has again published promising drill results, which could multiply the upcoming resource estimate. Plug Power is currently overshadowed by the Nucera IPO, but there is some interesting news.
Read
Commented by Juliane Zielonka on June 28th, 2023 | 07:40 CEST
Cardiol Therapeutics, Bayer, BASF - Sensational breakthroughs in medicine and sustainability
A study in the JACC journal shows that cardiovascular risk factors and diseases will increase sharply in the US. Ischemic heart disease is projected to increase by 31.1%, heart failure by 33.0% and myocardial infarction by 30.1%. Cardiol Therapeutics, a Canadian company specializing in cardiovascular diseases, is thus rapidly gaining in importance. Bayer goes AI and partners for the first time with a Swiss hospital for a digital solution that supports radiologists in diagnosis and treatment. BASF invests with its venture arm in the Swiss startup DePoly, which has developed an innovative chemical recycling technology. Discover the sustainable solution behind this investment here.
Read
Commented by Armin Schulz on June 28th, 2023 | 07:20 CEST
Barrick Gold, Desert Gold, Lanxess - After setbacks, is now a good time to buy?
An old merchant's rule states: The profit lies in the purchase. This wisdom can also be applied to stock market trading. As an investor, waiting for a setback before buying is always advisable. This avoids the danger of entering at a high. After the start of the banking crisis, the gold price soared, and those who bought then are now at a disadvantage. With the recent decline in the gold price, there may be an interesting opportunity to enter the market again. We, therefore, take a look at two gold companies. Finally, we will analyze Lanxess, whose shares recently suffered heavy losses.
Read
Commented by Nico Popp on June 28th, 2023 | 07:00 CEST
Bank shock and gold trickery: Deutsche Bank, Commerzbank, Globex Mining
Stress can be positive. That is when it sharpens our senses and is part of a constructive process. To be prepared for stress, banks undergo so-called stress tests. As the European banking supervisory authority has now reported, institutions must be prepared for negative surprises - the consequences for shareholders and customers are likely to be noticeable. We explain the situation and present alternatives.
Read